Mkts

Champions Oncology, Inc.

NASDAQ: CSBR
$4.81+0.00 (+0.00%)
As of Oct 30, 4:00 PM ET

Key statistics

Day range
4.764.95
52-week range
4.598.31
Today
Open4.86
Previous close4.81
Volume—
Valuation
Market cap66.81M
P/E ratio—
EPS (TTM)-0.08
Income & risk
Dividend / yield—
Beta0.41
Avg volume10.2K
Discussion

CSBR News

Stories mentioning CSBR from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Jan 31Q4 '25Oct 31Q3 '25Jul 31Q2 '25Apr 30Q1 '25Jan 31Q4 '24Oct 31Q3 '24Jul 31Q2 '24Apr 30
Income Statement
Revenue16,55915,03513,99512,35517,03913,48914,06114,002
Cost of Goods Sold8,8347,2627,9957,2726,6177,4287,0727,250
Gross Profit7,7257,7736,0005,08310,4226,0616,9896,752
Operating Expenses
Research & Development2,2712,6162,0821,9631,7191,6891,4542,050
Sales General & Admin
Total Operating Expenses
Operating Income (Loss)(276.00)185.00(527.00)(2,007)4,499732.001,329(272.00)
Interest Income
Interest Expense
Other Expense39.0070.0075.0042.0019.007.005.0081.00
Pretax Income(237.00)255.00(452.00)(1,965)4,518739.001,334(191.00)
Tax Provision42.0018.0014.00(130.00)23.0011.0021.00(82.00)
Net Income (Loss)(279.00)268.00(436.00)(1,835)4,495728.001,313(109.00)
Earnings Per Share (Basic)(0.02)0.02(0.03)(0.13)0.330.050.10(0.01)
Earnings Per Share (Diluted)(0.02)0.02(0.03)(0.13)0.310.050.09(0.01)
Weighted Average Shares Outstanding (Basic)13,88713,79213,78813,66013,70113,59413,59413,548
Weighted Average Shares Outstanding (Diluted)13,88714,45813,78814,26714,36514,01714,04213,548

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About CSBR

Champions Oncology, Inc. (NASDAQ: CSBR) is a stock listed on the Nasdaq Stock Market under the ticker symbol CSBR. It last traded at $4.81 (Oct 30, 2026, 4:00 PM ET), unchanged on the day. That gives Champions Oncology a market capitalisation of $66.8M.

Over the past 52 weeks CSBR has traded between $4.59 and $8.31.

Revenue for the quarter ended Jan 31, 2026 was $16.6M; a net loss of $279.0K. Revenue was down 2.8% from $17.0M in the quarter ended Jan 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Jan 31, 2026$16.6M-$279.0K-1.7%
Oct 31, 2025$15.0M$268.0K1.8%
Jul 31, 2025$14.0M-$436.0K-3.1%
Apr 30, 2025$12.4M-$1.8M-14.9%

From Champions Oncology’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…